Cargando…
Third‐generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long‐term follow‐up
OBJECTIVE: To assess long‐term hearing outcomes in patients treated with third‐generation bisphosphonates for otosclerosis‐related progressive sensorineural hearing loss (SNHL). STUDY DESIGN: Retrospective case series review METHODS: We performed a retrospective case series review of patients with o...
Autores principales: | Jan, Taha A., Remenschneider, Aaron K., Halpin, Christopher, Seton, Margaret, McKenna, Michael J., Quesnel, Alicia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655565/ https://www.ncbi.nlm.nih.gov/pubmed/29094069 http://dx.doi.org/10.1002/lio2.91 |
Ejemplares similares
-
Bisphosphonate therapy in otosclerosis: A scoping review
por: Zimmerer, René E., et al.
Publicado: (2022) -
Otopathology Findings in Otosclerosis With Lateral Semicircular Canal Fenestration
por: Dewyer, Nicholas A., et al.
Publicado: (2019) -
Benefits of Cochlear Implantation in Childhood Unilateral Hearing Loss (CUHL Trial)
por: Brown, Kevin D., et al.
Publicado: (2021) -
Facial nerve stimulation in adult cochlear implant recipients with far advanced otosclerosis
por: Tuset, Maria‐Pia, et al.
Publicado: (2022) -
Subjective Benefits of Bimodal Listening in Cochlear Implant Recipients with Asymmetric Hearing Loss
por: Thompson, Nicholas J., et al.
Publicado: (2020)